研究者業績

高根沢 康一

タカネザワ ヤスカズ  (Yasukazu Takanezawa)

基本情報

所属
武蔵野大学 生体防御機能学研究室 教授
学位
博士(薬学)(2002年3月 東京大学)

研究者番号
90345257
ORCID ID
 https://orcid.org/0000-0002-9220-5825
J-GLOBAL ID
202001012207827457
researchmap会員ID
R000007558

経歴

 7

論文

 55
  • Shimpei Uraguchi, Mikine Kimura, Yuka Ohshiro, Ryosuke Nakamura, Yasukazu Takanezawa, Masako Kiyono
    Plant Cell Reports 44(7) 2025年7月5日  査読有り
  • Yasukazu Takanezawa, Kazuma Sakai, Ryosuke Nakamura, Yuka Ohshiro, Shimpei Uraguchi, Masako Kiyono
    Biochemical and Biophysical Research Communications 151461-151461 2025年2月  査読有り筆頭著者責任著者
  • Shimpei Uraguchi, Masakazu Sato, Chihiro Hagai, Momoko Hirakawa, Kotomi Ogawa, Miyu Odagiri, Haruka Sato, Ayaka Ohmori, Yuka Ohshiro, Ryosuke Nakamura, Yasukazu Takanezawa, Masako Kiyono
    Plant Molecular Biology 115(1) 2024年12月18日  査読有り
  • Ryosuke Nakamura, Takashi Iwai, Yasukazu Takanezawa, Tatsuya Shirahata, Naruki Konishi, Yuka Ohshiro, Shimpei Uraguchi, Mitsuo Tanabe, Yoshinori Kobayashi, Kenji Sakamoto, Tsutomu Nakahara, Megumi Yamamoto, Masako Kiyono
    Toxicology 506 153867-153867 2024年8月  査読有り
  • Shimpei Uraguchi, Yuka Ohshiro, Kaede Abe, Yuta Tsuchiya, Ryosuke Nakamura, Yasukazu Takanezawa, Masako Kiyono
    SOIL SCIENCE AND PLANT NUTRITION 2023年7月  査読有り
  • Yasukazu Takanezawa, Ryosuke Nakamura, Yuka Ohshiro, Shimpei Uraguchi, Masako Kiyono
    Toxicology letters 383 196-203 2023年7月1日  査読有り筆頭著者
    Gadolinium-based contrast agents (GBCAs) are widely used in magnetic resonance imaging (MRI) to improve the sensitivity and enhance diagnostic performance. GBCAs are mostly eliminated from the body through the kidney after administration; however small amounts of gadolinium are retained in the brain and other tissues. Although there is increasing concern about the adverse health effects of gadolinium, the cellular effects of GBCAs remains poorly understood. Here, we elucidated the potential cytotoxicity of the GBCAs Omniscan and Gadovist in 12 different cell lines, especially 3T3-L1 adipocyte cell line. Omniscan and Gadovist treatments significantly increased intracellular gadolinium levels in 3T3-L1 cells in a time- and dose-dependent manner. Additionally, Omniscan and Gadovist treatments downregulated the expression of adipocyte differentiation markers, including peroxisome proliferator-activated receptor γ (PPARG), adiponectin (ADIPOQ), and fatty acid-binding protein (FABP4), in 3T3-L1 cells, especially during early differentiation (day 0-2). Moreover, histological analysis using Oil red O staining showed that gadolinium chloride (GdCl3) treatment suppressed lipid droplet accumulation and the expression of adipocyte differentiation markers. Overall, the results showed that Omniscan and Gadovist treatment suppressed adipocyte differentiation in 3T3-L1 cells, contributing to the understanding of the potential toxic effects of GBCA exposure.
  • Yasukazu Takanezawa, Yui Kashiwano, Ryosuke Nakamura, Yuka Ohshiro, Shimpei Uraguchi, Masako Kiyono
    Toxicology 486 153446-153446 2023年1月26日  査読有り筆頭著者
    Chronic exposure to methylmercury (MeHg) is positively associated with obesity and metabolic syndromes. However, the effect of MeHg on adipogenesis has not been thoroughly investigated. This study investigated the effects of continuous exposure to 0.5 µM MeHg on adipocyte differentiation in 3T3-L1 cells. Oil Red O staining and triglycerides (TG) assays demonstrated that MeHg enhanced the TG content in 3T3-L1 cells. MeHg enhanced the mRNA and protein expression of adipocyte differentiation markers including peroxisome proliferator-activated receptor γ, adiponectin, and fatty acid-binding protein, and their expression levels were prominent during the late stages (days 6-8) after the induction of differentiation. In addition, 0.5 µM MeHg promoted the expression of autophagy-related genes, including light chain 3 B-II and p62, after induction of differentiation. Treatment of 3T3-L1 cells with chloroquine (CQ), an autophagy inhibitor, during the early stages (days 0-2) after induction of differentiation inhibited cellular lipid accumulation in the presence of 0.5 µM MeHg. However, treatment with CQ during the late stages (days 6-8) had little effect on the MeHg-induced increase in TG content and the expression of adipocyte differentiation markers. Although the underlying mechanisms in the late stages remain to be completely elucidated, but the present data suggest that autophagy and other mechanisms play critical roles in adipogenesis during MeHg-induced differentiation. Collectively, our results suggest that continuous exposure to MeHg induces TG accumulation and expression of genes related to adipogenesis, especially during the late stages of 3T3-L1 differentiation, which may contribute to an improved understanding of MeHg-induced adipogenesis.
  • Masako Kiyono, Yuka Ohshiro, Ryosuke Nakamura, Shimpei Uraguchi, Yasukazu Takanezawa
    BPB Reports 6(4) 126-132 2023年  査読有り招待有り
  • Yasukazu Takanezawa, Kazuma Sakai, Ryosuke Nakamura, Yuka Ohshiro, Shimpei Uraguchi, Masako Kiyono
    Biological & pharmaceutical bulletin 46(9) 1203-1210 2023年  査読有り筆頭著者
    Methylmercury (MeHg) is a toxic metal that causes irreversible damage to the nervous system, making it a risk factor for neuronal degeneration and diseases. MeHg activates various cell signaling pathways, particularly the mitogen-activated protein kinase (MAPK) cascades, which are believed to be important determinants of stress-induced cell fate. However, little is known about the signaling pathways that mitigate the neurotoxic effects of MeHg. Herein, we showed that pretreatment with a p38 MAPK-specific inhibitor, SB203580, attenuates MeHg toxicity in human neuroblastoma SH-SY5Y cells, whereas pretreatment with the extracellular signaling-regulated kinase inhibitor U0126 and the c-Jun N-terminal kinase inhibitor SP600125 does not. Specifically, we quantified the levels of intracellular mercury (Hg) and found that pretreatment with SB203580 reduced Hg levels compared to MeHg treatment alone. Further analysis showed that pretreatment with SB203580 increased multidrug resistance-associated protein 2 (MRP2) mRNA levels after MeHg treatment. These results indicate that detoxification of MeHg by p38 MAPK inhibitors may involve an efflux function of MeHg by inducing MRP2 expression.
  • Yasukazu Takanezawa, Ryosuke Nakamura, Yuka Ohshiro, Shimpei Uraguchi, Masako Kiyono
    The Journal of toxicological sciences 48(6) 355-361 2023年  査読有り筆頭著者
    Methylmercury (MeHg), an environmental pollutant, disrupts and impairs cellular function. MeHg binds to various cellular proteins, causing dysfunction and misfolding, which are considered underlying causes of MeHg toxicity. The p62 protein, also termed SQSTM1, is a ubiquitin-binding protein that targets ubiquitinated substrates to undergo autophagy and plays a key role in ameliorating MeHg toxicity. p62 also delivers ubiquitinated substrates to proteasomes. However, the role of these degradation systems in mitigating MeHg toxicity remains unknown. Herein, we explored the impact of the proteasome inhibitor MG132 on MeHg toxicity and examined the toxicity of co-treatment with MG132 and MeHg in p62KO mouse embryonic fibroblasts (MEFs) by analyzing cell viability, immunoblotting, mRNA levels, immunofluorescence, and the mercury content. The proteasome inhibitor MG132 enhanced MeHg-induced cytotoxicity while reducing intracellular mercury levels in MEFs. Co-treatment with MG132 and MeHg markedly increased levels of p62 and ubiquitinated proteins. Furthermore, co-treatment with MG132 and MeHg reduced p62KO MEF viability compared to that of wild-type MEFs. Our findings suggest that the proteasome participates in mitigating MeHg cytotoxicity, while p62 may play an important role in transporting MeHg-induced ubiquitinated proteins to the proteasome, as well as in autophagy. Collectively, these results imply that p62, and proteasome, and autophagy are vital for cytoprotection against MeHg toxicity.
  • Shimpei Uraguchi, Yuka Ohshiro, Mayu Okuda, Shiho Kawakami, Nene Yoneyama, Yuta Tsuchiya, Ryosuke Nakamura, Yasukazu Takanezawa, Masako Kiyono
    FRONTIERS IN PLANT SCIENCE 13 2022年8月  査読有り
  • Yasukazu Takanezawa, Ryohei Harada, Yoshio Shibagaki, Yui Kashiwano, Ryosuke Nakamura, Yuka Ohshiro, Shimpei Uraguchi, Masako Kiyono
    Biochemical and biophysical research communications 609 134-140 2022年4月10日  査読有り筆頭著者責任著者
    SQSTM1/p62, hereinafter referred to as p62, is a stress-induced cellular protein that interacts with various signaling proteins as well as ubiquitinated proteins to regulate a variety of cellular functions and cell survival. Methylmercury (MeHg) exposure increases the levels of p62, the latter playing a protective role in MeHg-induced toxicity. However, the underlying mechanism by which p62 alleviates MeHg toxicity remains poorly understood. Herein, we report the interaction of p62 with neural precursor cell expressed developmentally down-regulated protein 4 (NEDD4), a HECT E3 ubiquitin ligase. The region of p62 where NEDD4 binds is located at the proline- and arginine (PR)-rich region (amino acids: 102-119), C-terminal extension of the Phox and Bem1 (PB1) domain. To evaluate the importance of the p62-NEDD4 complex, we examined the compensation of deletion mutant (GFP-Δ102-119 p62) for the lack of endogenous p62 in MEFs. GFP-p62/p62KO cells exhibited significantly higher cell viability than GFP-Δ102-119 p62/p62KO cells after treatment with MeHg. Our findings suggest novel mechanisms to alleviate MeHg toxicity through p62-NEDD4 complex formation.
  • Ryosuke Nakamura, Yasukazu Takanezawa, Yuka Ohshiro, Shimpei Uraguchi, Masako Kiyono
    Biochemistry and biophysics reports 29 101217-101217 2022年3月  査読有り筆頭著者
    Gadolinium-based contrast agents (GBCAs) are widely used to improve tissue contrast during magnetic resonance imaging. Exposure to GBCAs can result in gadolinium deposition within human tissues and has become a clinical concern because of the potential toxic effects of free gadolinium (Gd3+). Here, we report the impact of a single administration of GBCAs (Omniscan and Gadovist), and Gd3+ on mouse tissues. Five-week-old male BALB/c mice were injected intravenously with GBCAs or Gd3+. Seven days after injection, relatively high levels of gadolinium were detected in the spleen (118.87 nmol/g tissue), liver (83.00 nmol/g tissue), skin (48.56 nmol/g tissue), and kidneys (25.59 nmol/g tissue) of the Gd(NO3)3 (high dose: 0.165 mmol/kg) group; in the bones (11.12 nmol/g tissue), kidneys (7.49 nmol/g tissue), teeth (teeth: 6.18 nmol/g tissue), and skin (2.43 nmol/g tissue) of the Omniscan (high dose: 1.654 mmol/kg) group and in the kidneys (16.36 nmol/g tissue) and skin (4.88 nmol/g tissue) of the Gadovist (high dose: 3.308 mmol/kg) group. Enlargement of the spleen was observed in the Gd3+ group (p < 0.05), but not in the Omniscan or Gadovist groups. Gd3+ caused iron accumulation around the white pulp of the spleen, suggesting that enlargement of the spleen is, at least in part, associated with Gd3+ and/or iron accumulation. Our results may help elucidate the relative risks of different types of gadolinium agents, the mechanisms involved, and even recognition of potential toxic effects of GBCAs.
  • Shimpei Uraguchi, Kenichiro Nagai, Fumii Naruse, Yuto Otsuka, Yuka Ohshiro, Ryosuke Nakamura, Yasukazu Takanezawa, Masako Kiyono
    Metallomics : integrated biometal science 13(12) 2021年12月21日  査読有り
    For a better understanding of metal-ligand interaction and its function in cells, we developed an easy, sensitive, and high-throughput method to quantify ligand-metal(loid) binding affinity under physiological conditions by combining ligand-attached affinity beads and inductively coupled plasma-optical emission spectrometry (ICP-OES). Glutathione (GSH) and two phytochelatins (PC2 and PC3, small peptides with different numbers of free thiols) were employed as model ligands and attached to hydrophilic beads. The principle of the assay resembles that of affinity purification of proteins in biochemistry: metals binding to the ligand on the beads and the rest in the buffer are separated by a spin column and quantified by ICP-OES. The binding assay using the GSH-attached beads and various metal(loid)s suggested the different affinity of the metal-GSH interactions, in accordance with the order of the Irving-Williams series and the reported stability constants. The binding assay using PC2 or PC3-attached beads suggested positive binding between PCs and Ni(II), Cu(II), Zn(II), Cd(II), and As(III) in accordance with the number of thiols in PC2 and PC3. We then conducted the competition assay using Cd(II), Mn(II), Fe(II), Cu(II), and Zn(II), and the results suggested a better binding affinity of PC2 with Cd(II) than with the essential metals. Another competition assay using PC2 and GSH suggested a robust binding affinity between PCs and Cd(II) compared to GSH and Cd(II). These results suggested the dominance of PC-Cd complex formation in vitro, supporting the physiological importance of PCs for the detoxification of cadmium in vivo. We also discuss the potential application of the assay.
  • Yasukazu Takanezawa, Ryosuke Nakamura, Takuro Sugimoto, Yuka Ohshiro, Shimpei Uraguchi, Masako Kiyono
    Toxicology letters 353 93-99 2021年12月15日  査読有り筆頭著者責任著者
    Methylmercury (MeHg) is a hazardous environmental pollutant that causes serious toxicity in humans and animals, as well as proteotoxic stress. In our previous study, we found that MeHg induces the expression of p62/sequestosome 1 (p62) that selectively targets ubiquitinated proteins for degradation via autophagy, and that p62 might protect cells against MeHg toxicity. To further investigate the role of p62 in MeHg-induced stress responses, we evaluated the role of p62 in MeHg-induced endoplasmic reticulum (ER) stress in p62 knockout (p62KO) mouse embryonic fibroblasts (MEFs). Treatment of wild-type (WT) MEFs were treated with MeHg (1 μM) increased mRNA levels of Chop encoding C/EBP homologous protein, Trib3 encoding Tribbles homolog 3, and Dnajb9 encoding DnaJ heat-shock protein family (Hsp40) member B9 increased, suggesting that ER stress is elicited by MeHg stress. Additionally, p62KO MEFs treated with MeHg showed a higher mRNA expression of Chop and Trib3 relative to that in WT MEFs. Furthermore, knock-in of GFP-p62 to p62KO cells diminished the Chop and Trib3 induction responses to MeHg stress and resulted in a higher cell viability than that of p62KO MEFs. These results suggest that the protective role of p62 against MeHg toxicity is partly mediated by suppressing the ER stress response.
  • Shimpei Uraguchi, Yuka Ohshiro, Yuto Otsuka, Emiko Wada, Fumii Naruse, Kakeru Sugaya, Kenichiro Nagai, Arunee Wongkaew, Ryosuke Nakamura, Yasukazu Takanezawa, Stephan Clemens, Naoko Ohkama-Ohtsu, Masako Kiyono
    Plant molecular biology 109(4-5) 563-577 2021年11月27日  査読有り
    KEY MESSAGE: An organomercurial phenylmercury activates AtPCS1, an enzyme known for detoxification of inorganic metal(loid) ions in Arabidopsis and the induced metal-chelating peptides phytochelatins are essential for detoxification of phenylmercury. Small thiol-rich peptides phytochelatins (PCs) and their synthases (PCSs) are crucial for plants to mitigate the stress derived from various metal(loid) ions in their inorganic form including inorganic mercury [Hg(II)]. However, the possible roles of the PC/PCS system in organic mercury detoxification in plants remain elusive. We found that an organomercury phenylmercury (PheHg) induced PC synthesis in Arabidopsis thaliana plants as Hg(II), whereas methylmercury did not. The analyses of AtPCS1 mutant plants and in vitro assays using the AtPCS1-recombinant protein demonstrated that AtPCS1, the major PCS in A. thaliana, was responsible for the PheHg-responsive PC synthesis. AtPCS1 mutants cad1-3 and cad1-6, and the double mutant of PC-metal(loid) complex transporters AtABCC1 and AtABCC2 showed enhanced sensitivity to PheHg as well as to Hg(II). The hypersensitivity of cad1-3 to PheHg stress was complemented by the own-promoter-driven expression of AtPCS1-GFP. The confocal microscopy of the complementation lines showed that the AtPCS1-GFP was preferentially expressed in epidermal cells of the mature and elongation zones, and the outer-most layer of the lateral root cap cells in the meristematic zone. Moreover, in vitro PC-metal binding assay demonstrated that binding affinity between PC and PheHg was comparable to Hg(II). However, plant ionomic profiles, as well as root morphology under PheHg and Hg(II) stress, were divergent. These results suggest that PheHg phytotoxicity is different from Hg(II), but AtPCS1-mediated PC synthesis, complex formation, and vacuolar sequestration by AtABCC1 and AtABCC2 are similarly functional for both PheHg and Hg(II) detoxification in root surficial cell types.
  • Yuka Ohshiro, Shimpei Uraguchi, Ryosuke Nakamura, Yasukazu Takanezawa, Masako Kiyono
    FEMS microbiology letters 367(21) 2020年11月23日  査読有り
    Mercury superfamily proteins, i.e. inner membrane-spanning proteins (MerC, MerE, MerF and MerT) and a periplasmic mercury-binding protein (MerP), transport mercury into the cytoplasm. A previous study demonstrated that a Mer transporter homolog exhibits cadmium transport activity; based on this, the present study aimed to evaluate the cadmium transport activity of MerC, MerE, MerF and MerT and the effects of MerP co-expression in Escherichia coli. Bacteria expressing MerC, MerE, MerF or MerT without MerP were more sensitive to cadmium and significantly absorbed more cadmium than did the control strain. Expression of MerP in combination with MerC, MerE, MerF or MerT increased the bacterial sensitivity to cadmium and cadmium accumulation compared to a single expression of MerC, MerE, MerF or MerT. Cadmium uptake mediated by MerC, MerE, MerF or MerT was inhibited under cold or acidic conditions. These findings suggest that MerC, MerE, MerF and MerT are broad-spectrum heavy metal transporters that mediate both mercury and cadmium transport into cells and that MerP accelerates the cadmium transport ability of MerC, MerE, MerF and MerT.
  • Takanezawa Y, Nakamura R, Kusaka T, Ohshiro Y, Uraguchi S, Kiyono M
    Biochem Biophys Res Commun 526(1) 206-212 2020年5月21日  査読有り筆頭著者
  • Shimpei Uraguchi, Yuka Ohshiro, Yuto Otsuka, Hikari Tsukioka, Nene Yoneyama, Haruka Sato, Momoko Hirakawa, Ryosuke Nakamura, Yasukazu Takanezawa, Masako Kiyono
    Frontiers in plant science 11 503-503 2020年  査読有り
    For researchers in the plant metal field, the agar reagent used for the solid plate medium is a problematic factor because application of different agar types and even a different lot of the same agar type can mask the plant metal-related phenotypes and impair the reproducibility. In this study, we systematically assessed effects of different agar reagents on metal(loid) sensitivity and element accumulation of the Arabidopsis metal sensitive mutants. Three established mutants (cad1-3, cad1-6, and abcc1/2), and three different types of purified agar reagents (Type A, Type E, and Nacalai) with two independent batches for each reagent were subjected to the analyses. First, we found that element concentrations in the agar reagents largely varied among the agar types. Then the effects of agar reagents on the mutant metal(loid)-sensitivity were examined under As(III), Hg(II), Cd(II), and excess Zn(II) conditions. A significant variation of the mutant metal(loid)-sensitivity was observed among the different agar plates but the variation depended on the combination of metal(loid) stress and agar reagents. Briefly, the type-dependent variation was more evident under As(III) and Hg(II) than Cd(II) or excess Zn(II) conditions. A lot-dependent variation was also observed for Type A and Type E but not for Nacalai: hypersensitive phenotypes of cad1-3, cad1-6, and abcc1/2 under As(III) or Hg(II) treatments were diminished when different batches of the Type A or Type E agar types were used. We also found a significant variation of As and Hg accumulation in the wild-type and cad1-3. Plant As and Hg concentrations were remarkably higher and the difference between the genotypes was more evident when grown with Type A agar plates. We finally analyzed ionomic profiles in the plants exposed to As(III) stress. Agar-type specific ionomic changes in cad1-3 were more observed with the Type A plates than with the Nacalai plates. The presented results overall suggest that suitability of agar reagents for metal(loid)-related phenotyping depends on the experimental design, and an inappropriate selection of agar reagents can mask even very clear phenotypes of the established mutant like cad1-3. We also discuss perspectives on the agar problem in the plant metal study.
  • Takanezawa Y, Nakamura R, Matsuda H, Yagi T, Egawa Z, Sone Y, Uraguchi S, Adachi T, Kiyono M
    Toxicol Sci 170(2) 438-451 2019年8月1日  査読有り筆頭著者
  • Uraguchi S, Sone Y, Yoshikawa A, Tanabe M, Sato H, Otsuka Y, Nakamura R, Takanezawa Y, Kiyono M
    Planta 250(2) 667-674 2019年4月18日  査読有り
  • Takanezawa Y, Nakamura R, Sone Y, Uraguchi S, Kiyono M
    Biochem Biophys Res Commun 511(2) 460-467 2019年4月2日  査読有り筆頭著者責任著者
  • Nakamura R, Shirahata T, Konishi N, Takanezawa Y, Sone Y, Uraguchi S, Kobayashi Y, Kiyono M
    Toxicology 417 15-22 2019年4月1日  査読有り
  • Takanezawa Y, Nakamura R, Hamaguchi M, Yamamoto K, Sone Y, Uraguchi S, Kiyono M
    Toxicol Lett. 306 35-42 2019年3月15日  査読有り筆頭著者
  • Uraguchi S, Sone Y, Kamezawa M, Tanabe M, Hirakawa M, Nakamura R, Takanezawa Y, Kiyono M
    Sci Rep. 9(1) 4347 2019年3月13日  査読有り
  • Ryosuke Nakamura, Tatsuya Shirahata, Tatsuya Katsumi, Naruki Konishi, Yasukazu Takanezawa, Yuka Ohshiro, Shimpei Uraguchi, Yoshinori Kobayashi, Masako Kiyono
    BPB Reports 2(4) 56-60 2019年  
  • Takanezawa Y, Nakamura R, Kojima Y, Sone Y, Uraguchi S, Kiyono M
    Biochemical and Biophysical Research Communications 498 603-608 2018年3月9日  査読有り筆頭著者
  • Uraguchi S, Sone Y, Ohta Y, Ohkama-Ohtsu N, Hofmann C, Hess N, Nakamura R, Takanezawa Y, Clemens S, Kiyono M
    Plant and Cell Physiology 59(1) 500-509 2018年3月1日  査読有り
  • Takanezawa Y, Nakamura R, Sone Y, Uraguchi S, Kobayashi K, Tomoda H, Kiyono M
    Biochem Biophys Res Commun 494 641-647 2017年12月16日  査読有り筆頭著者
  • Sone Y, Uraguchi S, Takanezawa Y, Nakamura R, Pan-Hou H, Kiyono M
    FEBS Open Bio 7(12) 1994-1999 2017年12月4日  査読有り
  • Takanezawa Y, Nakamura R, Harada R, Sone Y, Uraguchi S, Kiyono M
    Scientific Reports 7 16735 2017年12月1日  査読有り筆頭著者
  • Uraguchi S, Tanaka N, Hofmann C, Abiko K, Ohkama-Ohtsu N, Weber M, Kamiya T, Sone Y, Nakamura R, Takanezawa Y, Kiyono M, Fujiwara T, Clemens S
    Plant and Cell Physiology 58(10) 1730-1742 2017年8月14日  査読有り
  • Sone Y, Uraguchi S, Takanezawa Y, Nakamura R, Pan-Hou H, Kiyono M
    Biological and Pharmaceutical Bulletin 40(7) 1125–1128-1128 2017年7月1日  査読有り
  • Takanezawa Y, Nakamura R, Sone Y, Uraguchi S, Kiyono M
    Toxicology Letters 262 135-141 2016年11月16日  査読有り筆頭著者責任著者
  • Nakamura R, Takanezawa Y, Sone Y, Uraguchi S, Sakabe K, Kiyono M
    Biological and Pharmaceutical Bulletin 39(8) 1353-1358 2016年8月1日  査読有り
  • Shichiri M, Takanezawa Y, Rotzolld D. E, Yoshida Y, Kokubu T, Uedae K, Tamai H, Arai H
    J Nutr Biochem. 21(5) 451-456 2010年5月21日  査読有り
  • Naru E, Takanezawa Y, Kobayashi M, Misaki Y, Kaji K, Arakane K
    Hum Cell. 21(3) 70-78 2008年8月21日  査読有り
  • Shichiri M, Takanezawa Y, Uchida K, Tamai H, Arai H
    Brain Res. 1182 106-115 2007年11月28日  査読有り
  • Yamaguchi N, Koizumi H, Aoki J, Natori Y, Nishikawa K, Natori Y, Takanezawa Y, Arai H
    Genes Cells. 12(10) 1153-1161 2007年10月12日  査読有り
  • Ban N, Matsumura Y, Sakai H, Takanezawa Y, Sasaki M, Arai H, Inagaki N
    J Biol Chem. 282(13) 9628-9634 2007年3月30日  査読有り
  • Morita S, Kobayashi A, Takanezawa Y, Kioka N, Handa T, Arai H, Matsuo M, Ueda K
    Hepatology 46(1) 188-199 2007年3月23日  査読有り
  • Ohtsuki M, Taketomi Y, Arata S, Masuda S, Ishikawa Y, Ishii T, Takanezawa Y, Aoki J, Arai H, Yamamoto K, Kudo I, Murakami M
    J Biol Chem. 281(47) 36420-36433 2006年11月24日  査読有り
  • Kamiya A, Tomoda T, Chang J, Takaki M, Zhan C, Morita M, Cascio MB, Elashvili S, Koizumi H, Takanezawa Y, Dickerson F, Yolken R, Arai H, Sawa A
    Hum Mol Genet. 15(22) 3313-3323 2006年11月15日  査読有り
  • Kobayashi A, Takanezawa Y, Hirata T, Shimizu Y, MisasaK, Kioka N, Arai H, Ueda K, Matsuo M
    Journal of Lipid Research 47(8) 1791-1802 2006年8月  査読有り
  • Okazaki H, Igarashi M, Nishi M, Tajima M, Sekiya M, Okazaki S, Yahagi N, Ohashi K, Tsukamoto K, Amemiya-Kudo M, Matsuzaka T, Shimano H, Yamada N, Aoki J, Morikawa R, Takanezawa Y, Arai H, Nagai R, Kadowaki T, Osuga J, Ishibashi S
    Diabetes. 55(7) 2091-2097 2006年7月  査読有り
  • Masuda S, Murakami M, Takanezawa Y, Aoki J, Arai H, Ishikawa Y, Ishii T, Arioka M, Kudo I
    J Biol Chem. 280(24) 23203-23214 2005年6月17日  査読有り
  • Xu Y, Aoki J, Shimizu K, Umezu-Goto M, Hama K, Takanezawa Y, Yu S, Mills GB, Arai H, Qian L, Prestwich GD
    J Med Chem. 48(9) 3319-3327 2005年5月5日  査読有り
  • Murakami M, Masuda S, Ueda-Semmyo K, Yoda E, Kuwata H, Takanezawa Y, Aoki J, Arai H, Sumimoto H, Ishikawa Y, Ishii T, Nakatani Y, Kudo I
    J Biol Chem. 280(14) 14028-14041 2005年4月8日  査読有り
  • Tanaka M, Kishi Y, Takanezawa Y, Kakehi Y, Aoki J, Arai H
    FEBS Lett. 571(1-3) 197-204 2004年7月30日  査読有り
  • Tamura Y, Osuga J, Adachi H, Tozawa R, Takanezawa Y, Ohashi K, Yahagi N, Sekiya M, Okazaki H, Tomita S, Iizuka Y, Koizumi H, Inaba T, Yagyu H, Kamada N, Suzuki H, Shimano H, Kadowaki T, Tsujimoto M, Arai H, Yamada N, Ishibashi S
    J Biol Chem. 279(30) 30938-30944 2004年7月23日  査読有り

MISC

 37

講演・口頭発表等

 149

担当経験のある科目(授業)

 6

共同研究・競争的資金等の研究課題

 8